Neoprobe Corporation

Description

Neoprobe Corporation is focused on developing and commercializing innovative biomedical products that meet the critical intraoperative, diagnostic and therapeutic treatment needs of patients and physicians. Our primary area of focus is in improving cancer surgery outcomes by using our market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents.We have also recently formed another majority-owned subsidiary, Cira Biosciences, Inc., to explore the development and commercialization of an activated cellular therapy technology that has shown promising early stage patient-specific treatment potential in oncology, viral (HIV/AIDS and hepatitis) and autoimmune diseases."Neoprobe Corporation is committed to providing products and services which meet or exceed our customers' expectations. We will continue to improve the quality of these products and services by advancing our technology and by seeking to understand customer requirements."

Fact sheet

Company contacts

Products & services

Similar companies nearby